Oncology and Hematology - MedEd On The Go

Episodes 1-16 of 58

Guideline Recommendations in First-Line Treatment of HER2-Negative Upper GI Cancers
Guideline Recommendations in First-Line Treatment of HER2-Negative Upper GI Cancers
MinuteCE®
Guideline Recommendations in First-Line Treatment of HER2-Negative Upper GI Cancers
0.50 program credits
- James M. Cleary, MD, PhD
0.50 program credits
Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer
Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer
MinuteCE®
Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer
0.50 program credits
- James M. Cleary, MD, PhD
0.50 program credits
Distinguishing First-Line Treatment Adverse Event Profiles in HER2-Negative Upper GI Cancers
Distinguishing First-Line Treatment Adverse Event Profiles in HER2-Negative Upper GI Cancers
MinuteCE®
Distinguishing First-Line Treatment Adverse Event Profiles in HER2-Negative Upper GI Cancers
0.50 program credits
- James M. Cleary, MD, PhD
0.50 program credits
MinuteCE®
Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-Making  
0.50 credits 4 episodes
- James M. Cleary, MD, PhD
0.50 credits 4 episodes
Pivotal Data in Anti-PD-1 Strategies for HER2-Negative Upper GI Cancers  
Pivotal Data in Anti-PD-1 Strategies for HER2-Negative Upper GI Cancers  
MinuteCE®
Pivotal Data in Anti-PD-1 Strategies for HER2-Negative Upper GI Cancers  
0.50 program credits
- James M. Cleary, MD, PhD
0.50 program credits
Emerging Evidence for Perioperative ICIs in Locally Advanced HNSCC
Emerging Evidence for Perioperative ICIs in Locally Advanced HNSCC
MinuteCE®
Emerging Evidence for Perioperative ICIs in Locally Advanced HNSCC
0.75 program credits
- Ravindra Uppaluri, MD, PhD
0.75 program credits
Multidisciplinary Collaboration Facilitates Multimodality Therapy
Multidisciplinary Collaboration Facilitates Multimodality Therapy
MinuteCE®
Multidisciplinary Collaboration Facilitates Multimodality Therapy
0.75 program credits
- Douglas Adkins, MD
- Ravindra Uppaluri, MD, PhD
- Nancy Lee, MD, FASTRO
0.75 program credits
Risk Stratification and Patient Selection for Perioperative ICIs
Risk Stratification and Patient Selection for Perioperative ICIs
MinuteCE®
Risk Stratification and Patient Selection for Perioperative ICIs
0.75 program credits
- Douglas Adkins, MD
0.75 program credits
Resectable Head & Neck Cancer: A Team-Based Approach to Perioperative Immunotherapy
Resectable Head & Neck Cancer: A Team-Based Approach to Perioperative Immunotherapy
CME/CE
Resectable Head & Neck Cancer: A Team-Based Approach to Perioperative Immunotherapy
0.25 credits
- Robert Haddad, MD
- Ravindra Uppaluri, MD, PhD
- Nancy Lee, MD, FASTRO
0.25 credits
Managing Immune-Related Adverse Events in the Perioperative Setting
Managing Immune-Related Adverse Events in the Perioperative Setting
MinuteCE®
Managing Immune-Related Adverse Events in the Perioperative Setting
0.75 program credits
- Douglas Adkins, MD
0.75 program credits
Applying Perioperative ICIs in Clinical Practice
Applying Perioperative ICIs in Clinical Practice
MinuteCE®
Applying Perioperative ICIs in Clinical Practice
0.75 program credits
- Douglas Adkins, MD
0.75 program credits
The Evolving Landscape of Resectable Locally Advanced HNSCC
The Evolving Landscape of Resectable Locally Advanced HNSCC
MinuteCE®
The Evolving Landscape of Resectable Locally Advanced HNSCC
0.75 program credits
- Ravindra Uppaluri, MD, PhD
0.75 program credits
MinuteCE®
Advancing Care in Locally Advanced HNSCC: Integrating Perioperative Immunotherapy and Multimodal Strategies
0.75 credits 7 episodes
- Douglas Adkins, MD
- Ravindra Uppaluri, MD, PhD
- Nancy Lee, MD, FASTRO
0.75 credits 7 episodes
Rationale for Combining Radiation and Immunotherapy in Resectable Locally Advanced HNSCC
Rationale for Combining Radiation and Immunotherapy in Resectable Locally Advanced HNSCC
MinuteCE®
Rationale for Combining Radiation and Immunotherapy in Resectable Locally Advanced HNSCC
0.75 program credits
- Nancy Lee, MD, FASTRO
0.75 program credits
Stratifying Risk to Guide Therapy in R/R AML 
Stratifying Risk to Guide Therapy in R/R AML 
MinuteCE®
Stratifying Risk to Guide Therapy in R/R AML 
1.00 program credit
- Ghayas Issa, MD
- Amir Fathi, MD
1.00 program credit
Menin Inhibitors: Biologic and Clinical Rationale 
Menin Inhibitors: Biologic and Clinical Rationale 
MinuteCE®
Menin Inhibitors: Biologic and Clinical Rationale 
1.00 program credit
- Ghayas Issa, MD
- Amir Fathi, MD
1.00 program credit

Prev
1
2
3
4
Next

1/4